nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—chronic obstructive pulmonary disease—asthma	0.168	1	CtDrD
Arformoterol—Formoterol—asthma	0.101	0.545	CrCtD
Arformoterol—Isoprenaline—asthma	0.0846	0.455	CrCtD
Arformoterol—Adrenergic beta2-Agonists—Salmeterol—asthma	0.0539	0.181	CiPCiCtD
Arformoterol—Adrenergic beta2-Agonists—Indacaterol—asthma	0.0539	0.181	CiPCiCtD
Arformoterol—Adrenergic beta2-Agonists—Orciprenaline—asthma	0.0539	0.181	CiPCiCtD
Arformoterol—Adrenergic beta2-Agonists—Pirbuterol—asthma	0.0539	0.181	CiPCiCtD
Arformoterol—ADRB2—asthma	0.0508	1	CbGaD
Arformoterol—Adrenergic beta2-Agonists—Formoterol—asthma	0.0408	0.137	CiPCiCtD
Arformoterol—Adrenergic beta2-Agonists—Salbutamol—asthma	0.0408	0.137	CiPCiCtD
Arformoterol—ADRB2—Orciprenaline—asthma	0.0113	0.0889	CbGbCtD
Arformoterol—Arbutamine—Salmeterol—asthma	0.0105	0.0845	CrCrCtD
Arformoterol—Fenoterol—Orciprenaline—asthma	0.0105	0.0845	CrCrCtD
Arformoterol—Dobutamine—Formoterol—asthma	0.0103	0.0826	CrCrCtD
Arformoterol—Formoterol—Isoprenaline—asthma	0.00957	0.0767	CrCrCtD
Arformoterol—Fenoterol—Terbutaline—asthma	0.00914	0.0732	CrCrCtD
Arformoterol—ADRB2—Pirbuterol—asthma	0.00859	0.0674	CbGbCtD
Arformoterol—ADRB2—Terbutaline—asthma	0.00859	0.0674	CbGbCtD
Arformoterol—ADRB2—Isoetarine—asthma	0.00859	0.0674	CbGbCtD
Arformoterol—ADRB1—Isoetarine—asthma	0.00846	0.0664	CbGbCtD
Arformoterol—ADRB1—Pirbuterol—asthma	0.00846	0.0664	CbGbCtD
Arformoterol—Fenoterol—Formoterol—asthma	0.00799	0.064	CrCrCtD
Arformoterol—Ritodrine—Formoterol—asthma	0.00799	0.064	CrCrCtD
Arformoterol—Arbutamine—Formoterol—asthma	0.00699	0.056	CrCrCtD
Arformoterol—Labetalol—Salmeterol—asthma	0.00668	0.0536	CrCrCtD
Arformoterol—Fenoterol—Isoprenaline—asthma	0.00666	0.0534	CrCrCtD
Arformoterol—Isoprenaline—Orciprenaline—asthma	0.00605	0.0485	CrCrCtD
Arformoterol—ADRB2—Indacaterol—asthma	0.00595	0.0467	CbGbCtD
Arformoterol—ADRB1—Indacaterol—asthma	0.00586	0.046	CbGbCtD
Arformoterol—Arbutamine—Isoprenaline—asthma	0.00583	0.0467	CrCrCtD
Arformoterol—ADRB2—Salbutamol—asthma	0.00553	0.0434	CbGbCtD
Arformoterol—ADRB2—Salmeterol—asthma	0.00553	0.0434	CbGbCtD
Arformoterol—ADRB1—Salbutamol—asthma	0.00545	0.0428	CbGbCtD
Arformoterol—Isoprenaline—Terbutaline—asthma	0.00525	0.0421	CrCrCtD
Arformoterol—Isoprenaline—Isoetarine—asthma	0.00505	0.0405	CrCrCtD
Arformoterol—ADRB2—Isoprenaline—asthma	0.00471	0.0369	CbGbCtD
Arformoterol—ADRB1—Isoprenaline—asthma	0.00463	0.0364	CbGbCtD
Arformoterol—Isoprenaline—Formoterol—asthma	0.00459	0.0368	CrCrCtD
Arformoterol—Labetalol—Formoterol—asthma	0.00443	0.0355	CrCrCtD
Arformoterol—ADRB2—Formoterol—asthma	0.00419	0.0329	CbGbCtD
Arformoterol—ADRB1—Formoterol—asthma	0.00413	0.0324	CbGbCtD
Arformoterol—Labetalol—Isoprenaline—asthma	0.00369	0.0296	CrCrCtD
Arformoterol—Isoprenaline—Salbutamol—asthma	0.00348	0.0279	CrCrCtD
Arformoterol—CYP2A6—Formoterol—asthma	0.00334	0.0262	CbGbCtD
Arformoterol—CYP2A6—Montelukast—asthma	0.00253	0.0199	CbGbCtD
Arformoterol—CYP2D6—Ciclesonide—asthma	0.00149	0.0117	CbGbCtD
Arformoterol—CYP2A6—Prednisolone—asthma	0.00149	0.0117	CbGbCtD
Arformoterol—CYP2C19—Zafirlukast—asthma	0.00143	0.0112	CbGbCtD
Arformoterol—CYP2C19—Formoterol—asthma	0.00138	0.0109	CbGbCtD
Arformoterol—CYP2C9—Zileuton—asthma	0.00135	0.0106	CbGbCtD
Arformoterol—CYP2D6—Ipratropium bromide—asthma	0.00124	0.00971	CbGbCtD
Arformoterol—CYP2C9—Zafirlukast—asthma	0.00119	0.00935	CbGbCtD
Arformoterol—CYP2C9—Formoterol—asthma	0.00115	0.00903	CbGbCtD
Arformoterol—CYP2D6—Zafirlukast—asthma	0.00109	0.00855	CbGbCtD
Arformoterol—CYP2D6—Formoterol—asthma	0.00105	0.00825	CbGbCtD
Arformoterol—CYP2C19—Loratadine—asthma	0.00105	0.00823	CbGbCtD
Arformoterol—CYP2D6—Tiotropium—asthma	0.000937	0.00736	CbGbCtD
Arformoterol—CYP2C9—Theophylline—asthma	0.00092	0.00722	CbGbCtD
Arformoterol—CYP2A6—Dexamethasone—asthma	0.000877	0.00688	CbGbCtD
Arformoterol—CYP2C9—Loratadine—asthma	0.000872	0.00684	CbGbCtD
Arformoterol—CYP2C9—Montelukast—asthma	0.000872	0.00684	CbGbCtD
Arformoterol—CYP2D6—Theophylline—asthma	0.000841	0.0066	CbGbCtD
Arformoterol—CYP2D6—Loratadine—asthma	0.000797	0.00626	CbGbCtD
Arformoterol—CYP2C19—Prednisone—asthma	0.000581	0.00456	CbGbCtD
Arformoterol—CYP2C19—Dexamethasone—asthma	0.000363	0.00285	CbGbCtD
Arformoterol—CYP2C9—Dexamethasone—asthma	0.000302	0.00237	CbGbCtD
Arformoterol—CYP2D6—Dexamethasone—asthma	0.000276	0.00216	CbGbCtD
Arformoterol—Ritodrine—ADRB2—asthma	8.92e-05	0.171	CrCbGaD
Arformoterol—Fenoterol—ADRB2—asthma	8.92e-05	0.171	CrCbGaD
Arformoterol—Arbutamine—ADRB2—asthma	8.34e-05	0.16	CrCbGaD
Arformoterol—Formoterol—ADRB2—asthma	8.1e-05	0.155	CrCbGaD
Arformoterol—Dobutamine—ADRB2—asthma	7.68e-05	0.147	CrCbGaD
Arformoterol—Labetalol—ADRB2—asthma	5.92e-05	0.113	CrCbGaD
Arformoterol—Isoprenaline—ADRB2—asthma	4.36e-05	0.0834	CrCbGaD
Arformoterol—Rash—Montelukast—asthma	5.26e-06	0.000131	CcSEcCtD
Arformoterol—Dermatitis—Montelukast—asthma	5.25e-06	0.000131	CcSEcCtD
Arformoterol—Ill-defined disorder—Prednisolone—asthma	5.24e-06	0.00013	CcSEcCtD
Arformoterol—Headache—Montelukast—asthma	5.22e-06	0.00013	CcSEcCtD
Arformoterol—Visual impairment—Betamethasone—asthma	5.22e-06	0.00013	CcSEcCtD
Arformoterol—Visual impairment—Dexamethasone—asthma	5.22e-06	0.00013	CcSEcCtD
Arformoterol—Mental disorder—Methylprednisolone—asthma	5.22e-06	0.00013	CcSEcCtD
Arformoterol—Malnutrition—Methylprednisolone—asthma	5.18e-06	0.000129	CcSEcCtD
Arformoterol—Acute coronary syndrome—Prednisone—asthma	5.18e-06	0.000129	CcSEcCtD
Arformoterol—Angioedema—Prednisolone—asthma	5.16e-06	0.000128	CcSEcCtD
Arformoterol—Myocardial infarction—Prednisone—asthma	5.15e-06	0.000128	CcSEcCtD
Arformoterol—Dizziness—Budesonide—asthma	5.15e-06	0.000128	CcSEcCtD
Arformoterol—Ill-defined disorder—Hydrocortisone—asthma	5.12e-06	0.000127	CcSEcCtD
Arformoterol—Vomiting—Salbutamol—asthma	5.11e-06	0.000127	CcSEcCtD
Arformoterol—Malaise—Prednisolone—asthma	5.1e-06	0.000127	CcSEcCtD
Arformoterol—Dysgeusia—Triamcinolone—asthma	5.09e-06	0.000126	CcSEcCtD
Arformoterol—Rash—Salbutamol—asthma	5.07e-06	0.000126	CcSEcCtD
Arformoterol—Dermatitis—Salbutamol—asthma	5.06e-06	0.000126	CcSEcCtD
Arformoterol—Nausea—Formoterol—asthma	5.06e-06	0.000126	CcSEcCtD
Arformoterol—Angioedema—Hydrocortisone—asthma	5.04e-06	0.000125	CcSEcCtD
Arformoterol—Headache—Salbutamol—asthma	5.04e-06	0.000125	CcSEcCtD
Arformoterol—Back pain—Triamcinolone—asthma	5.03e-06	0.000125	CcSEcCtD
Arformoterol—Malaise—Hydrocortisone—asthma	4.98e-06	0.000124	CcSEcCtD
Arformoterol—Nausea—Montelukast—asthma	4.95e-06	0.000123	CcSEcCtD
Arformoterol—Vomiting—Budesonide—asthma	4.95e-06	0.000123	CcSEcCtD
Arformoterol—Rash—Budesonide—asthma	4.91e-06	0.000122	CcSEcCtD
Arformoterol—Dermatitis—Budesonide—asthma	4.91e-06	0.000122	CcSEcCtD
Arformoterol—Headache—Budesonide—asthma	4.88e-06	0.000121	CcSEcCtD
Arformoterol—Hypertension—Prednisolone—asthma	4.88e-06	0.000121	CcSEcCtD
Arformoterol—Arrhythmia—Betamethasone—asthma	4.84e-06	0.00012	CcSEcCtD
Arformoterol—Arrhythmia—Dexamethasone—asthma	4.84e-06	0.00012	CcSEcCtD
Arformoterol—Ill-defined disorder—Triamcinolone—asthma	4.82e-06	0.00012	CcSEcCtD
Arformoterol—Ill-defined disorder—Methylprednisolone—asthma	4.81e-06	0.000119	CcSEcCtD
Arformoterol—Nausea—Salbutamol—asthma	4.78e-06	0.000119	CcSEcCtD
Arformoterol—Hypertension—Hydrocortisone—asthma	4.76e-06	0.000118	CcSEcCtD
Arformoterol—Discomfort—Prednisolone—asthma	4.75e-06	0.000118	CcSEcCtD
Arformoterol—Angioedema—Triamcinolone—asthma	4.75e-06	0.000118	CcSEcCtD
Arformoterol—Angioedema—Methylprednisolone—asthma	4.74e-06	0.000118	CcSEcCtD
Arformoterol—Myalgia—Hydrocortisone—asthma	4.7e-06	0.000117	CcSEcCtD
Arformoterol—Malaise—Triamcinolone—asthma	4.69e-06	0.000116	CcSEcCtD
Arformoterol—Anxiety—Hydrocortisone—asthma	4.68e-06	0.000116	CcSEcCtD
Arformoterol—Malaise—Methylprednisolone—asthma	4.68e-06	0.000116	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	4.67e-06	0.000116	CcSEcCtD
Arformoterol—Discomfort—Hydrocortisone—asthma	4.64e-06	0.000115	CcSEcCtD
Arformoterol—Connective tissue disorder—Prednisone—asthma	4.63e-06	0.000115	CcSEcCtD
Arformoterol—Nausea—Budesonide—asthma	4.63e-06	0.000115	CcSEcCtD
Arformoterol—Anaphylactic shock—Prednisolone—asthma	4.61e-06	0.000115	CcSEcCtD
Arformoterol—Oedema—Prednisolone—asthma	4.61e-06	0.000115	CcSEcCtD
Arformoterol—Cough—Triamcinolone—asthma	4.53e-06	0.000113	CcSEcCtD
Arformoterol—Anaphylactic shock—Hydrocortisone—asthma	4.5e-06	0.000112	CcSEcCtD
Arformoterol—Oedema—Hydrocortisone—asthma	4.5e-06	0.000112	CcSEcCtD
Arformoterol—Tachycardia—Prednisolone—asthma	4.5e-06	0.000112	CcSEcCtD
Arformoterol—Hypertension—Triamcinolone—asthma	4.49e-06	0.000111	CcSEcCtD
Arformoterol—Hypertension—Methylprednisolone—asthma	4.48e-06	0.000111	CcSEcCtD
Arformoterol—Infection—Hydrocortisone—asthma	4.47e-06	0.000111	CcSEcCtD
Arformoterol—Myalgia—Triamcinolone—asthma	4.42e-06	0.00011	CcSEcCtD
Arformoterol—Nervous system disorder—Hydrocortisone—asthma	4.42e-06	0.00011	CcSEcCtD
Arformoterol—Myalgia—Methylprednisolone—asthma	4.41e-06	0.00011	CcSEcCtD
Arformoterol—Arthralgia—Methylprednisolone—asthma	4.41e-06	0.00011	CcSEcCtD
Arformoterol—Anxiety—Methylprednisolone—asthma	4.4e-06	0.000109	CcSEcCtD
Arformoterol—Tachycardia—Hydrocortisone—asthma	4.4e-06	0.000109	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	4.38e-06	0.000109	CcSEcCtD
Arformoterol—Skin disorder—Hydrocortisone—asthma	4.37e-06	0.000109	CcSEcCtD
Arformoterol—Ill-defined disorder—Betamethasone—asthma	4.37e-06	0.000109	CcSEcCtD
Arformoterol—Ill-defined disorder—Dexamethasone—asthma	4.37e-06	0.000109	CcSEcCtD
Arformoterol—Discomfort—Triamcinolone—asthma	4.37e-06	0.000109	CcSEcCtD
Arformoterol—Discomfort—Methylprednisolone—asthma	4.36e-06	0.000108	CcSEcCtD
Arformoterol—Dry mouth—Triamcinolone—asthma	4.33e-06	0.000107	CcSEcCtD
Arformoterol—Angioedema—Dexamethasone—asthma	4.31e-06	0.000107	CcSEcCtD
Arformoterol—Angioedema—Betamethasone—asthma	4.31e-06	0.000107	CcSEcCtD
Arformoterol—Immune system disorder—Prednisone—asthma	4.26e-06	0.000106	CcSEcCtD
Arformoterol—Malaise—Dexamethasone—asthma	4.25e-06	0.000106	CcSEcCtD
Arformoterol—Malaise—Betamethasone—asthma	4.25e-06	0.000106	CcSEcCtD
Arformoterol—Oedema—Triamcinolone—asthma	4.24e-06	0.000105	CcSEcCtD
Arformoterol—Anaphylactic shock—Triamcinolone—asthma	4.24e-06	0.000105	CcSEcCtD
Arformoterol—Anaphylactic shock—Methylprednisolone—asthma	4.23e-06	0.000105	CcSEcCtD
Arformoterol—Arrhythmia—Prednisone—asthma	4.21e-06	0.000105	CcSEcCtD
Arformoterol—Infection—Triamcinolone—asthma	4.21e-06	0.000105	CcSEcCtD
Arformoterol—Hypotension—Hydrocortisone—asthma	4.21e-06	0.000105	CcSEcCtD
Arformoterol—Infection—Methylprednisolone—asthma	4.2e-06	0.000104	CcSEcCtD
Arformoterol—Insomnia—Prednisolone—asthma	4.17e-06	0.000104	CcSEcCtD
Arformoterol—Nervous system disorder—Methylprednisolone—asthma	4.15e-06	0.000103	CcSEcCtD
Arformoterol—Tachycardia—Triamcinolone—asthma	4.14e-06	0.000103	CcSEcCtD
Arformoterol—Mental disorder—Prednisone—asthma	4.13e-06	0.000103	CcSEcCtD
Arformoterol—Tachycardia—Methylprednisolone—asthma	4.13e-06	0.000103	CcSEcCtD
Arformoterol—Skin disorder—Methylprednisolone—asthma	4.11e-06	0.000102	CcSEcCtD
Arformoterol—Malnutrition—Prednisone—asthma	4.11e-06	0.000102	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Hydrocortisone—asthma	4.1e-06	0.000102	CcSEcCtD
Arformoterol—Insomnia—Hydrocortisone—asthma	4.07e-06	0.000101	CcSEcCtD
Arformoterol—Hypertension—Dexamethasone—asthma	4.07e-06	0.000101	CcSEcCtD
Arformoterol—Hypertension—Betamethasone—asthma	4.07e-06	0.000101	CcSEcCtD
Arformoterol—Myalgia—Dexamethasone—asthma	4.01e-06	9.97e-05	CcSEcCtD
Arformoterol—Myalgia—Betamethasone—asthma	4.01e-06	9.97e-05	CcSEcCtD
Arformoterol—Anxiety—Betamethasone—asthma	4e-06	9.94e-05	CcSEcCtD
Arformoterol—Anxiety—Dexamethasone—asthma	4e-06	9.94e-05	CcSEcCtD
Arformoterol—Discomfort—Dexamethasone—asthma	3.97e-06	9.85e-05	CcSEcCtD
Arformoterol—Discomfort—Betamethasone—asthma	3.97e-06	9.85e-05	CcSEcCtD
Arformoterol—Dyspepsia—Hydrocortisone—asthma	3.96e-06	9.85e-05	CcSEcCtD
Arformoterol—Hypotension—Methylprednisolone—asthma	3.95e-06	9.82e-05	CcSEcCtD
Arformoterol—Pain—Prednisolone—asthma	3.94e-06	9.8e-05	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Hydrocortisone—asthma	3.89e-06	9.66e-05	CcSEcCtD
Arformoterol—Fatigue—Hydrocortisone—asthma	3.88e-06	9.65e-05	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Triamcinolone—asthma	3.86e-06	9.6e-05	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Methylprednisolone—asthma	3.85e-06	9.58e-05	CcSEcCtD
Arformoterol—Pain—Hydrocortisone—asthma	3.85e-06	9.57e-05	CcSEcCtD
Arformoterol—Anaphylactic shock—Dexamethasone—asthma	3.85e-06	9.56e-05	CcSEcCtD
Arformoterol—Oedema—Dexamethasone—asthma	3.85e-06	9.56e-05	CcSEcCtD
Arformoterol—Oedema—Betamethasone—asthma	3.85e-06	9.56e-05	CcSEcCtD
Arformoterol—Anaphylactic shock—Betamethasone—asthma	3.85e-06	9.56e-05	CcSEcCtD
Arformoterol—Insomnia—Triamcinolone—asthma	3.84e-06	9.53e-05	CcSEcCtD
Arformoterol—Insomnia—Methylprednisolone—asthma	3.83e-06	9.51e-05	CcSEcCtD
Arformoterol—Infection—Betamethasone—asthma	3.82e-06	9.5e-05	CcSEcCtD
Arformoterol—Infection—Dexamethasone—asthma	3.82e-06	9.5e-05	CcSEcCtD
Arformoterol—Ill-defined disorder—Prednisone—asthma	3.81e-06	9.46e-05	CcSEcCtD
Arformoterol—Feeling abnormal—Prednisolone—asthma	3.8e-06	9.44e-05	CcSEcCtD
Arformoterol—Dyspnoea—Triamcinolone—asthma	3.78e-06	9.39e-05	CcSEcCtD
Arformoterol—Nervous system disorder—Dexamethasone—asthma	3.77e-06	9.37e-05	CcSEcCtD
Arformoterol—Nervous system disorder—Betamethasone—asthma	3.77e-06	9.37e-05	CcSEcCtD
Arformoterol—Agitation—Prednisone—asthma	3.77e-06	9.37e-05	CcSEcCtD
Arformoterol—Tachycardia—Betamethasone—asthma	3.76e-06	9.33e-05	CcSEcCtD
Arformoterol—Tachycardia—Dexamethasone—asthma	3.76e-06	9.33e-05	CcSEcCtD
Arformoterol—Angioedema—Prednisone—asthma	3.75e-06	9.32e-05	CcSEcCtD
Arformoterol—Dyspepsia—Triamcinolone—asthma	3.73e-06	9.27e-05	CcSEcCtD
Arformoterol—Dyspepsia—Methylprednisolone—asthma	3.72e-06	9.25e-05	CcSEcCtD
Arformoterol—Feeling abnormal—Hydrocortisone—asthma	3.71e-06	9.22e-05	CcSEcCtD
Arformoterol—Malaise—Prednisone—asthma	3.7e-06	9.2e-05	CcSEcCtD
Arformoterol—Gastrointestinal pain—Hydrocortisone—asthma	3.68e-06	9.15e-05	CcSEcCtD
Arformoterol—Urticaria—Prednisolone—asthma	3.66e-06	9.1e-05	CcSEcCtD
Arformoterol—Fatigue—Triamcinolone—asthma	3.66e-06	9.08e-05	CcSEcCtD
Arformoterol—Fatigue—Methylprednisolone—asthma	3.65e-06	9.06e-05	CcSEcCtD
Arformoterol—Pain—Triamcinolone—asthma	3.63e-06	9.01e-05	CcSEcCtD
Arformoterol—Hypotension—Dexamethasone—asthma	3.6e-06	8.93e-05	CcSEcCtD
Arformoterol—Hypotension—Betamethasone—asthma	3.6e-06	8.93e-05	CcSEcCtD
Arformoterol—Urticaria—Hydrocortisone—asthma	3.58e-06	8.89e-05	CcSEcCtD
Arformoterol—Abdominal pain—Hydrocortisone—asthma	3.56e-06	8.84e-05	CcSEcCtD
Arformoterol—Body temperature increased—Hydrocortisone—asthma	3.56e-06	8.84e-05	CcSEcCtD
Arformoterol—Hypertension—Prednisone—asthma	3.54e-06	8.81e-05	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Dexamethasone—asthma	3.51e-06	8.71e-05	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Betamethasone—asthma	3.51e-06	8.71e-05	CcSEcCtD
Arformoterol—Myalgia—Prednisone—asthma	3.5e-06	8.68e-05	CcSEcCtD
Arformoterol—Arthralgia—Prednisone—asthma	3.5e-06	8.68e-05	CcSEcCtD
Arformoterol—Feeling abnormal—Triamcinolone—asthma	3.49e-06	8.68e-05	CcSEcCtD
Arformoterol—Feeling abnormal—Methylprednisolone—asthma	3.49e-06	8.66e-05	CcSEcCtD
Arformoterol—Anxiety—Prednisone—asthma	3.48e-06	8.65e-05	CcSEcCtD
Arformoterol—Insomnia—Betamethasone—asthma	3.48e-06	8.65e-05	CcSEcCtD
Arformoterol—Insomnia—Dexamethasone—asthma	3.48e-06	8.65e-05	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	3.47e-06	8.62e-05	CcSEcCtD
Arformoterol—Gastrointestinal pain—Methylprednisolone—asthma	3.46e-06	8.59e-05	CcSEcCtD
Arformoterol—Discomfort—Prednisone—asthma	3.45e-06	8.58e-05	CcSEcCtD
Arformoterol—Hypersensitivity—Prednisolone—asthma	3.4e-06	8.44e-05	CcSEcCtD
Arformoterol—Dyspepsia—Dexamethasone—asthma	3.39e-06	8.41e-05	CcSEcCtD
Arformoterol—Dyspepsia—Betamethasone—asthma	3.39e-06	8.41e-05	CcSEcCtD
Arformoterol—Urticaria—Triamcinolone—asthma	3.37e-06	8.37e-05	CcSEcCtD
Arformoterol—Urticaria—Methylprednisolone—asthma	3.36e-06	8.35e-05	CcSEcCtD
Arformoterol—Body temperature increased—Triamcinolone—asthma	3.35e-06	8.33e-05	CcSEcCtD
Arformoterol—Oedema—Prednisone—asthma	3.35e-06	8.32e-05	CcSEcCtD
Arformoterol—Anaphylactic shock—Prednisone—asthma	3.35e-06	8.32e-05	CcSEcCtD
Arformoterol—Abdominal pain—Methylprednisolone—asthma	3.34e-06	8.31e-05	CcSEcCtD
Arformoterol—Infection—Prednisone—asthma	3.33e-06	8.27e-05	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Betamethasone—asthma	3.32e-06	8.25e-05	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Dexamethasone—asthma	3.32e-06	8.25e-05	CcSEcCtD
Arformoterol—Hypersensitivity—Hydrocortisone—asthma	3.32e-06	8.24e-05	CcSEcCtD
Arformoterol—Fatigue—Dexamethasone—asthma	3.32e-06	8.24e-05	CcSEcCtD
Arformoterol—Fatigue—Betamethasone—asthma	3.32e-06	8.24e-05	CcSEcCtD
Arformoterol—Pain—Dexamethasone—asthma	3.29e-06	8.17e-05	CcSEcCtD
Arformoterol—Pain—Betamethasone—asthma	3.29e-06	8.17e-05	CcSEcCtD
Arformoterol—Nervous system disorder—Prednisone—asthma	3.29e-06	8.16e-05	CcSEcCtD
Arformoterol—Tachycardia—Prednisone—asthma	3.27e-06	8.12e-05	CcSEcCtD
Arformoterol—Skin disorder—Prednisone—asthma	3.25e-06	8.09e-05	CcSEcCtD
Arformoterol—Asthenia—Hydrocortisone—asthma	3.23e-06	8.03e-05	CcSEcCtD
Arformoterol—Pruritus—Hydrocortisone—asthma	3.19e-06	7.92e-05	CcSEcCtD
Arformoterol—Feeling abnormal—Dexamethasone—asthma	3.17e-06	7.88e-05	CcSEcCtD
Arformoterol—Feeling abnormal—Betamethasone—asthma	3.17e-06	7.88e-05	CcSEcCtD
Arformoterol—Gastrointestinal pain—Betamethasone—asthma	3.15e-06	7.82e-05	CcSEcCtD
Arformoterol—Gastrointestinal pain—Dexamethasone—asthma	3.15e-06	7.82e-05	CcSEcCtD
Arformoterol—Hypersensitivity—Triamcinolone—asthma	3.12e-06	7.76e-05	CcSEcCtD
Arformoterol—Hypersensitivity—Methylprednisolone—asthma	3.12e-06	7.74e-05	CcSEcCtD
Arformoterol—Diarrhoea—Hydrocortisone—asthma	3.08e-06	7.65e-05	CcSEcCtD
Arformoterol—Urticaria—Dexamethasone—asthma	3.06e-06	7.59e-05	CcSEcCtD
Arformoterol—Urticaria—Betamethasone—asthma	3.06e-06	7.59e-05	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Prednisone—asthma	3.05e-06	7.58e-05	CcSEcCtD
Arformoterol—Dizziness—Prednisolone—asthma	3.05e-06	7.58e-05	CcSEcCtD
Arformoterol—Asthenia—Triamcinolone—asthma	3.04e-06	7.56e-05	CcSEcCtD
Arformoterol—Abdominal pain—Dexamethasone—asthma	3.04e-06	7.56e-05	CcSEcCtD
Arformoterol—Abdominal pain—Betamethasone—asthma	3.04e-06	7.56e-05	CcSEcCtD
Arformoterol—Body temperature increased—Betamethasone—asthma	3.04e-06	7.56e-05	CcSEcCtD
Arformoterol—Body temperature increased—Dexamethasone—asthma	3.04e-06	7.56e-05	CcSEcCtD
Arformoterol—Asthenia—Methylprednisolone—asthma	3.04e-06	7.54e-05	CcSEcCtD
Arformoterol—Insomnia—Prednisone—asthma	3.03e-06	7.53e-05	CcSEcCtD
Arformoterol—Pruritus—Triamcinolone—asthma	3e-06	7.45e-05	CcSEcCtD
Arformoterol—Pruritus—Methylprednisolone—asthma	2.99e-06	7.44e-05	CcSEcCtD
Arformoterol—Dizziness—Hydrocortisone—asthma	2.98e-06	7.4e-05	CcSEcCtD
Arformoterol—Dyspepsia—Prednisone—asthma	2.95e-06	7.33e-05	CcSEcCtD
Arformoterol—Rash—Prednisolone—asthma	2.91e-06	7.22e-05	CcSEcCtD
Arformoterol—Dermatitis—Prednisolone—asthma	2.9e-06	7.22e-05	CcSEcCtD
Arformoterol—Diarrhoea—Methylprednisolone—asthma	2.89e-06	7.19e-05	CcSEcCtD
Arformoterol—Fatigue—Prednisone—asthma	2.89e-06	7.18e-05	CcSEcCtD
Arformoterol—Headache—Prednisolone—asthma	2.89e-06	7.18e-05	CcSEcCtD
Arformoterol—Constipation—Prednisone—asthma	2.87e-06	7.12e-05	CcSEcCtD
Arformoterol—Vomiting—Hydrocortisone—asthma	2.86e-06	7.11e-05	CcSEcCtD
Arformoterol—Rash—Hydrocortisone—asthma	2.84e-06	7.05e-05	CcSEcCtD
Arformoterol—Dermatitis—Hydrocortisone—asthma	2.84e-06	7.05e-05	CcSEcCtD
Arformoterol—Headache—Hydrocortisone—asthma	2.82e-06	7.01e-05	CcSEcCtD
Arformoterol—Dizziness—Triamcinolone—asthma	2.8e-06	6.97e-05	CcSEcCtD
Arformoterol—Dizziness—Methylprednisolone—asthma	2.8e-06	6.95e-05	CcSEcCtD
Arformoterol—Feeling abnormal—Prednisone—asthma	2.76e-06	6.86e-05	CcSEcCtD
Arformoterol—Asthenia—Dexamethasone—asthma	2.76e-06	6.86e-05	CcSEcCtD
Arformoterol—Asthenia—Betamethasone—asthma	2.76e-06	6.86e-05	CcSEcCtD
Arformoterol—Gastrointestinal pain—Prednisone—asthma	2.74e-06	6.81e-05	CcSEcCtD
Arformoterol—Nausea—Prednisolone—asthma	2.74e-06	6.8e-05	CcSEcCtD
Arformoterol—Pruritus—Betamethasone—asthma	2.72e-06	6.76e-05	CcSEcCtD
Arformoterol—Pruritus—Dexamethasone—asthma	2.72e-06	6.76e-05	CcSEcCtD
Arformoterol—Vomiting—Triamcinolone—asthma	2.7e-06	6.7e-05	CcSEcCtD
Arformoterol—Vomiting—Methylprednisolone—asthma	2.69e-06	6.68e-05	CcSEcCtD
Arformoterol—Nausea—Hydrocortisone—asthma	2.68e-06	6.65e-05	CcSEcCtD
Arformoterol—Rash—Triamcinolone—asthma	2.67e-06	6.64e-05	CcSEcCtD
Arformoterol—Dermatitis—Triamcinolone—asthma	2.67e-06	6.64e-05	CcSEcCtD
Arformoterol—Rash—Methylprednisolone—asthma	2.67e-06	6.63e-05	CcSEcCtD
Arformoterol—Dermatitis—Methylprednisolone—asthma	2.67e-06	6.62e-05	CcSEcCtD
Arformoterol—Urticaria—Prednisone—asthma	2.66e-06	6.61e-05	CcSEcCtD
Arformoterol—Headache—Triamcinolone—asthma	2.66e-06	6.6e-05	CcSEcCtD
Arformoterol—Headache—Methylprednisolone—asthma	2.65e-06	6.58e-05	CcSEcCtD
Arformoterol—Abdominal pain—Prednisone—asthma	2.65e-06	6.58e-05	CcSEcCtD
Arformoterol—Body temperature increased—Prednisone—asthma	2.65e-06	6.58e-05	CcSEcCtD
Arformoterol—Diarrhoea—Betamethasone—asthma	2.63e-06	6.54e-05	CcSEcCtD
Arformoterol—Diarrhoea—Dexamethasone—asthma	2.63e-06	6.54e-05	CcSEcCtD
Arformoterol—Dizziness—Dexamethasone—asthma	2.54e-06	6.32e-05	CcSEcCtD
Arformoterol—Dizziness—Betamethasone—asthma	2.54e-06	6.32e-05	CcSEcCtD
Arformoterol—Nausea—Triamcinolone—asthma	2.52e-06	6.26e-05	CcSEcCtD
Arformoterol—Nausea—Methylprednisolone—asthma	2.51e-06	6.24e-05	CcSEcCtD
Arformoterol—Hypersensitivity—Prednisone—asthma	2.47e-06	6.13e-05	CcSEcCtD
Arformoterol—Vomiting—Dexamethasone—asthma	2.45e-06	6.08e-05	CcSEcCtD
Arformoterol—Vomiting—Betamethasone—asthma	2.45e-06	6.08e-05	CcSEcCtD
Arformoterol—Rash—Betamethasone—asthma	2.43e-06	6.03e-05	CcSEcCtD
Arformoterol—Rash—Dexamethasone—asthma	2.43e-06	6.03e-05	CcSEcCtD
Arformoterol—Dermatitis—Betamethasone—asthma	2.42e-06	6.02e-05	CcSEcCtD
Arformoterol—Dermatitis—Dexamethasone—asthma	2.42e-06	6.02e-05	CcSEcCtD
Arformoterol—Headache—Dexamethasone—asthma	2.41e-06	5.99e-05	CcSEcCtD
Arformoterol—Headache—Betamethasone—asthma	2.41e-06	5.99e-05	CcSEcCtD
Arformoterol—Asthenia—Prednisone—asthma	2.4e-06	5.97e-05	CcSEcCtD
Arformoterol—Pruritus—Prednisone—asthma	2.37e-06	5.89e-05	CcSEcCtD
Arformoterol—ADRB1—Signaling Pathways—PDE4B—asthma	2.31e-06	0.000428	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—TACR1—asthma	2.31e-06	0.000428	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—CXCL8—asthma	2.31e-06	0.000428	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—CSF2—asthma	2.31e-06	0.000428	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CARM1—asthma	2.3e-06	0.000427	CbGpPWpGaD
Arformoterol—Diarrhoea—Prednisone—asthma	2.29e-06	5.7e-05	CcSEcCtD
Arformoterol—Nausea—Dexamethasone—asthma	2.29e-06	5.68e-05	CcSEcCtD
Arformoterol—Nausea—Betamethasone—asthma	2.29e-06	5.68e-05	CcSEcCtD
Arformoterol—ADRB2—Signaling by GPCR—ITPR1—asthma	2.27e-06	0.000421	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—DCN—asthma	2.27e-06	0.00042	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—C5—asthma	2.26e-06	0.000419	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PDE4B—asthma	2.26e-06	0.000419	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—TACR1—asthma	2.26e-06	0.000419	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—CXCL8—asthma	2.26e-06	0.000418	CbGpPWpGaD
Arformoterol—Dizziness—Prednisone—asthma	2.22e-06	5.5e-05	CcSEcCtD
Arformoterol—CYP2D6—Metabolism—ARG1—asthma	2.21e-06	0.00041	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—ALDH2—asthma	2.21e-06	0.000409	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ARG1—asthma	2.2e-06	0.000407	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—EDN1—asthma	2.19e-06	0.000406	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ALDH7A1—asthma	2.18e-06	0.000404	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—CCL5—asthma	2.17e-06	0.000403	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—PLA2G4A—asthma	2.17e-06	0.000401	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—CCR5—asthma	2.16e-06	0.0004	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—EDN1—asthma	2.14e-06	0.000397	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—CSF2—asthma	2.14e-06	0.000397	CbGpPWpGaD
Arformoterol—Vomiting—Prednisone—asthma	2.13e-06	5.29e-05	CcSEcCtD
Arformoterol—ADRB2—Signaling by GPCR—CCL5—asthma	2.13e-06	0.000394	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—IL2RA—asthma	2.13e-06	0.000394	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—PLA2G4A—asthma	2.12e-06	0.000393	CbGpPWpGaD
Arformoterol—Rash—Prednisone—asthma	2.11e-06	5.25e-05	CcSEcCtD
Arformoterol—ADRB1—Signaling Pathways—CCR3—asthma	2.11e-06	0.000391	CbGpPWpGaD
Arformoterol—Dermatitis—Prednisone—asthma	2.11e-06	5.24e-05	CcSEcCtD
Arformoterol—ADRB2—GPCR downstream signaling—CCR5—asthma	2.11e-06	0.000391	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—C3—asthma	2.11e-06	0.000391	CbGpPWpGaD
Arformoterol—Headache—Prednisone—asthma	2.1e-06	5.21e-05	CcSEcCtD
Arformoterol—CYP2A6—Metabolism—GSTT1—asthma	2.1e-06	0.000389	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—CSF2—asthma	2.1e-06	0.000388	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ARG2—asthma	2.09e-06	0.000387	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—IL2RA—asthma	2.08e-06	0.000385	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CCR3—asthma	2.07e-06	0.000383	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—C3—asthma	2.06e-06	0.000382	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NPY—asthma	2.06e-06	0.000381	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NPY—asthma	2.01e-06	0.000373	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ALDH7A1—asthma	2e-06	0.000371	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—PPP2CA—asthma	2e-06	0.00037	CbGpPWpGaD
Arformoterol—Nausea—Prednisone—asthma	1.99e-06	4.94e-05	CcSEcCtD
Arformoterol—ADRB1—Signaling Pathways—AGTR2—asthma	1.99e-06	0.000368	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ALDH7A1—asthma	1.99e-06	0.000368	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—CCR5—asthma	1.96e-06	0.000363	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—PPP2CA—asthma	1.95e-06	0.000362	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—AGTR2—asthma	1.94e-06	0.00036	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—IL2RA—asthma	1.93e-06	0.000358	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ARG2—asthma	1.92e-06	0.000356	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—CCR5—asthma	1.92e-06	0.000355	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—C3—asthma	1.91e-06	0.000355	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ARG2—asthma	1.9e-06	0.000353	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—EDNRB—asthma	1.9e-06	0.000352	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—IL2RA—asthma	1.89e-06	0.00035	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NPS—asthma	1.88e-06	0.000349	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—TAC1—asthma	1.88e-06	0.000349	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—C3—asthma	1.87e-06	0.000347	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—EDNRB—asthma	1.86e-06	0.000345	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CXCR3—asthma	1.85e-06	0.000342	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—TAC1—asthma	1.84e-06	0.000341	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NPS—asthma	1.84e-06	0.000341	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	1.83e-06	0.000339	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CXCR3—asthma	1.81e-06	0.000335	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CYBA—asthma	1.79e-06	0.000331	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PARP1—asthma	1.75e-06	0.000324	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IL5—asthma	1.75e-06	0.000324	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CYBA—asthma	1.75e-06	0.000324	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—NQO1—asthma	1.74e-06	0.000323	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ALOX5AP—asthma	1.73e-06	0.000321	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ALOX15—asthma	1.73e-06	0.000321	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IL5—asthma	1.71e-06	0.000317	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PARP1—asthma	1.71e-06	0.000317	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—ADCY2—asthma	1.71e-06	0.000316	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—BDKRB2—asthma	1.69e-06	0.000313	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—POMC—asthma	1.69e-06	0.000312	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	1.67e-06	0.000309	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—BDKRB2—asthma	1.65e-06	0.000306	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CHAT—asthma	1.65e-06	0.000306	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—POMC—asthma	1.65e-06	0.000306	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—ADCY2—asthma	1.63e-06	0.000303	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IL3—asthma	1.63e-06	0.000302	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—ADCY2—asthma	1.6e-06	0.000296	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IL3—asthma	1.59e-06	0.000295	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ALOX5AP—asthma	1.59e-06	0.000295	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ALOX15—asthma	1.59e-06	0.000295	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ALOX5AP—asthma	1.58e-06	0.000292	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ALOX15—asthma	1.58e-06	0.000292	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—KNG1—asthma	1.54e-06	0.000285	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—POMC—asthma	1.53e-06	0.000284	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—AGTR1—asthma	1.53e-06	0.000283	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CHAT—asthma	1.52e-06	0.000281	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CHAT—asthma	1.5e-06	0.000279	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—KNG1—asthma	1.5e-06	0.000279	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—CCL2—asthma	1.5e-06	0.000278	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—POMC—asthma	1.5e-06	0.000278	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—AGTR1—asthma	1.49e-06	0.000277	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—IL6R—asthma	1.49e-06	0.000277	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CXCL10—asthma	1.49e-06	0.000277	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—RHOA—asthma	1.49e-06	0.000275	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ALOX5—asthma	1.47e-06	0.000273	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—CCL2—asthma	1.47e-06	0.000272	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NTRK1—asthma	1.46e-06	0.000271	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—IL6R—asthma	1.46e-06	0.000271	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CXCL10—asthma	1.46e-06	0.000271	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—GSTP1—asthma	1.45e-06	0.00027	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—RHOA—asthma	1.45e-06	0.000269	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—ADRB2—asthma	1.45e-06	0.000268	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—HMOX1—asthma	1.43e-06	0.000266	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NTRK1—asthma	1.43e-06	0.000265	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—ITPR1—asthma	1.43e-06	0.000265	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CAT—asthma	1.42e-06	0.000262	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CARM1—asthma	1.4e-06	0.00026	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—DCN—asthma	1.38e-06	0.000256	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—ITPR1—asthma	1.37e-06	0.000254	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ALOX5—asthma	1.35e-06	0.000251	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—RHOA—asthma	1.35e-06	0.00025	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ALDH2—asthma	1.35e-06	0.000249	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ALOX5—asthma	1.34e-06	0.000249	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—ITPR1—asthma	1.34e-06	0.000248	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PLA2G4A—asthma	1.34e-06	0.000248	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—GSTM1—asthma	1.34e-06	0.000248	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—RHOA—asthma	1.32e-06	0.000245	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CD86—asthma	1.3e-06	0.000242	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—CXCL8—asthma	1.3e-06	0.000242	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—EDN1—asthma	1.29e-06	0.00024	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—asthma	1.29e-06	0.00024	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CARM1—asthma	1.29e-06	0.000239	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CCL5—asthma	1.28e-06	0.000238	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GSTT1—asthma	1.28e-06	0.000237	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PLA2G4A—asthma	1.28e-06	0.000237	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CARM1—asthma	1.28e-06	0.000237	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CD86—asthma	1.28e-06	0.000237	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—CXCL8—asthma	1.28e-06	0.000236	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—DCN—asthma	1.27e-06	0.000236	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—EDN1—asthma	1.27e-06	0.000235	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CSF2—asthma	1.27e-06	0.000235	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—DCN—asthma	1.26e-06	0.000234	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CCL5—asthma	1.26e-06	0.000233	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PLA2G4A—asthma	1.25e-06	0.000232	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—IL2—asthma	1.25e-06	0.000231	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CSF2—asthma	1.24e-06	0.000229	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ALDH2—asthma	1.24e-06	0.000229	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—SMAD3—asthma	1.23e-06	0.000228	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PPP2CA—asthma	1.23e-06	0.000228	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ALDH2—asthma	1.23e-06	0.000227	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—IL2—asthma	1.22e-06	0.000226	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—SMAD3—asthma	1.21e-06	0.000223	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—CXCL8—asthma	1.18e-06	0.00022	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—asthma	1.18e-06	0.000219	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—asthma	1.18e-06	0.000219	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PPP2CA—asthma	1.18e-06	0.000218	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GSTT1—asthma	1.18e-06	0.000218	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GSTT1—asthma	1.17e-06	0.000216	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—CXCL8—asthma	1.16e-06	0.000215	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CCR5—asthma	1.16e-06	0.000214	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PPP2CA—asthma	1.15e-06	0.000214	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IL2RA—asthma	1.14e-06	0.000211	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CCR5—asthma	1.13e-06	0.00021	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—IL2—asthma	1.13e-06	0.00021	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—C3—asthma	1.13e-06	0.00021	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IL2RA—asthma	1.12e-06	0.000207	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—IL2—asthma	1.11e-06	0.000205	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—C3—asthma	1.11e-06	0.000205	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PDGFB—asthma	1.1e-06	0.000204	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PDGFB—asthma	1.08e-06	0.0002	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—asthma	1.08e-06	0.000199	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—NQO1—asthma	1.06e-06	0.000197	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—LEP—asthma	1.05e-06	0.000195	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ADCY2—asthma	1.04e-06	0.000193	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—asthma	1.03e-06	0.000191	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—LEP—asthma	1.03e-06	0.000191	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—FN1—asthma	9.93e-07	0.000184	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—NQO1—asthma	9.78e-07	0.000181	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—FN1—asthma	9.71e-07	0.00018	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—NQO1—asthma	9.7e-07	0.00018	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ADCY2—asthma	9.57e-07	0.000177	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ADCY2—asthma	9.49e-07	0.000176	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—POMC—asthma	9.45e-07	0.000175	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—asthma	9.41e-07	0.000174	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—POMC—asthma	9.05e-07	0.000168	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—asthma	9e-07	0.000167	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GSTP1—asthma	8.87e-07	0.000164	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CCL2—asthma	8.85e-07	0.000164	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—POMC—asthma	8.85e-07	0.000164	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IL6R—asthma	8.82e-07	0.000164	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—HMOX1—asthma	8.75e-07	0.000162	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ITPR1—asthma	8.73e-07	0.000162	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—EGFR—asthma	8.66e-07	0.00016	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CCL2—asthma	8.66e-07	0.00016	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CAT—asthma	8.63e-07	0.00016	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IL6R—asthma	8.63e-07	0.00016	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—ALB—asthma	8.62e-07	0.00016	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—EGFR—asthma	8.47e-07	0.000157	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—SERPINE1—asthma	8.26e-07	0.000153	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—NOS3—asthma	8.24e-07	0.000153	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—asthma	8.21e-07	0.000152	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GSTP1—asthma	8.16e-07	0.000151	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PLA2G4A—asthma	8.15e-07	0.000151	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GSTM1—asthma	8.15e-07	0.000151	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GSTP1—asthma	8.09e-07	0.00015	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—SERPINE1—asthma	8.08e-07	0.00015	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—HMOX1—asthma	8.05e-07	0.000149	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ITPR1—asthma	8.03e-07	0.000149	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—HMOX1—asthma	7.98e-07	0.000148	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—RHOA—asthma	7.97e-07	0.000148	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ITPR1—asthma	7.96e-07	0.000147	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CAT—asthma	7.94e-07	0.000147	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NOS3—asthma	7.89e-07	0.000146	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CAT—asthma	7.87e-07	0.000146	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—RHOA—asthma	7.8e-07	0.000144	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NOS3—asthma	7.72e-07	0.000143	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PTGS2—asthma	7.54e-07	0.00014	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PPP2CA—asthma	7.51e-07	0.000139	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PLA2G4A—asthma	7.5e-07	0.000139	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GSTM1—asthma	7.5e-07	0.000139	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PLA2G4A—asthma	7.43e-07	0.000138	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GSTM1—asthma	7.43e-07	0.000138	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CXCL8—asthma	7e-07	0.00013	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PPP2CA—asthma	6.9e-07	0.000128	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PPP2CA—asthma	6.85e-07	0.000127	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CXCL8—asthma	6.84e-07	0.000127	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IL2—asthma	6.69e-07	0.000124	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—IL6—asthma	6.65e-07	0.000123	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PTEN—asthma	6.57e-07	0.000122	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IL2—asthma	6.54e-07	0.000121	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—IL6—asthma	6.51e-07	0.000121	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MMP9—asthma	6.33e-07	0.000117	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PTEN—asthma	6.29e-07	0.000117	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MMP9—asthma	6.19e-07	0.000115	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PTEN—asthma	6.15e-07	0.000114	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—POMC—asthma	5.76e-07	0.000107	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—VEGFA—asthma	5.68e-07	0.000105	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—STAT3—asthma	5.63e-07	0.000104	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—VEGFA—asthma	5.56e-07	0.000103	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—STAT3—asthma	5.5e-07	0.000102	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—POMC—asthma	5.3e-07	9.82e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—POMC—asthma	5.25e-07	9.74e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ALB—asthma	5.25e-07	9.73e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—TGFB1—asthma	5.22e-07	9.67e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—EGFR—asthma	5.11e-07	9.48e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—TGFB1—asthma	5.1e-07	9.46e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—NOS3—asthma	5.02e-07	9.31e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—EGFR—asthma	5e-07	9.27e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ALB—asthma	4.83e-07	8.95e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ALB—asthma	4.79e-07	8.88e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—NOS3—asthma	4.62e-07	8.56e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PTGS2—asthma	4.6e-07	8.52e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—NOS3—asthma	4.58e-07	8.49e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PTGS2—asthma	4.23e-07	7.83e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PTGS2—asthma	4.19e-07	7.77e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PTEN—asthma	4.01e-07	7.43e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IL6—asthma	3.93e-07	7.28e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IL6—asthma	3.84e-07	7.13e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PTEN—asthma	3.69e-07	6.83e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PTEN—asthma	3.65e-07	6.77e-05	CbGpPWpGaD
